Business Opportunities
Epeius Biotechnologies Corporation is a privately-held biopharmaceutical company dedicated to the advancement of genetic medicine with the development and commercialization of its targeted delivery systems and innovative high-value oncology products. By the strategic campaigning of critical R&D activities—combined with the remarkable innovation, dedication, and outstanding performance of its entire staff—Epeius Biotechnologies has accomplished a large number of product development and clinical milestones, positioning the company to build upon these achievements while limiting the overall costs of operations. Product Registration in the Philippines, along with triple Orphan Drug Designation in the U.S. and positive results in four U.S. clinical trials, has placed Epeius Biotech and Rexin-G at the cusp of financial and commercial success.
Accordingly, Epeius Biotech has entered into a number of strategic partnerships and alliances for GMP manufacturing, clinical operations, and product distribution to centers in the Philippines and the U.S. With continued expansion of clinical activities worldwide, and the attainment of additional regulatory approvals, Epeius Biotechnologies anticipates the establishment of new partnerships, licensing arrangements, and corporate alliances that will propel the development of our high-value oncology products along a fully integrated path. Prospective value-added partners that exhibit the integrity of purpose and demonstrated capability of developing innovative products in the field of biotechnology and/or and medical oncology are welcome to participate.
Recent expansion of GMP capabilities in Carlsbad, California, includes a 40,000 square foot state-of-the-art facility (shown below) designed for robotic operations that will increase production capacities while providing economies-of-scale in the manufacturing of targeted genetic medicine.
Epeius Biotechnologies, Biopharmaceutical Division, in Carlsbad, CA
